Wang T - Search Results

1

The deubiquitylating enzyme USP35 restricts regulated cell death to promote survival of renal clear cell carcinoma.

Wang S, Wang T, Zhang X, Cheng S, Chen C, Yang G, Wang F, Wang R, Zhang Q, Yang D, Zhang Y, Liu S, Qin H, Liu Q, Liu H. Wang S, et al. Among authors: wang f, wang t, wang r. Cell Death Differ. 2023 Jul;30(7):1757-1770. doi: 10.1038/s41418-023-01176-3. Epub 2023 May 12. Cell Death Differ. 2023. PMID: 37173391 Free PMC article.

2

Neratinib induces ErbB2 ubiquitylation and endocytic degradation via HSP90 dissociation in breast cancer cells.

Zhang Y, Zhang J, Liu C, Du S, Feng L, Luan X, Zhang Y, Shi Y, Wang T, Wu Y, Cheng W, Meng S, Li M, Liu H. Zhang Y, et al. Among authors: wang t. Cancer Lett. 2016 Nov 28;382(2):176-185. doi: 10.1016/j.canlet.2016.08.026. Epub 2016 Sep 3. Cancer Lett. 2016. PMID: 27597738

3

The USP7 Inhibitor P5091 Induces Cell Death in Ovarian Cancers with Different P53 Status.

Wang M, Zhang Y, Wang T, Zhang J, Zhou Z, Sun Y, Wang S, Shi Y, Luan X, Zhang Y, Wang Y, Wang Y, Zou Z, Kang L, Liu H. Wang M, et al. Among authors: wang y, wang t, wang s. Cell Physiol Biochem. 2017;43(5):1755-1766. doi: 10.1159/000484062. Epub 2017 Oct 19. Cell Physiol Biochem. 2017. PMID: 29049989 Free article.

4

The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms.

Wang T, Zhang J, Wang S, Sun X, Wang D, Gao Y, Zhang Y, Xu L, Wu Y, Wu Y, Liu F, Liu X, Liu S, Zhang Y, Wang Y, Zou L, Liu H. Wang T, et al. Among authors: wang y, wang d, wang s. Cell Commun Signal. 2018 Jul 5;16(1):40. doi: 10.1186/s12964-018-0245-y. Cell Commun Signal. 2018. PMID: 29976202 Free PMC article.

5

Dynasore-induced potent ubiquitylation of the exon 19 deletion mutant of epidermal growth factor receptor suppresses cell growth and migration in non-small cell lung cancer.

Wang T, Wang D, Zhang Y, Zhang J, Sun X, Wu Y, Wang S, Zhang Y, Xu L, Kong Q, Gao Y, Wu Y, Liu F, Liu S, Zhang Y, Lei T, Liu H. Wang T, et al. Among authors: wang d, wang s. Int J Biochem Cell Biol. 2018 Dec;105:1-12. doi: 10.1016/j.biocel.2018.09.017. Epub 2018 Sep 28. Int J Biochem Cell Biol. 2018. PMID: 30268747

6

Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects.

Xu L, Zhang Y, Tian K, Chen X, Zhang R, Mu X, Wu Y, Wang D, Wang S, Liu F, Wang T, Zhang J, Liu S, Zhang Y, Tu C, Liu H. Xu L, et al. Among authors: wang d, wang t, wang s. J Exp Clin Cancer Res. 2018 Oct 29;37(1):261. doi: 10.1186/s13046-018-0929-6. J Exp Clin Cancer Res. 2018. PMID: 30373602 Free PMC article.

7

Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer.

Zhang J, Li Q, Wu Y, Wang D, Xu L, Zhang Y, Wang S, Wang T, Liu F, Zaky MY, Hou S, Liu S, Zou K, Lei H, Zou L, Zhang Y, Liu H. Zhang J, et al. Among authors: wang d, wang t, wang s. Cell Commun Signal. 2019 Feb 20;17(1):15. doi: 10.1186/s12964-019-0328-4. Cell Commun Signal. 2019. PMID: 30786890 Free PMC article.

8

Endocytic degradation of ErbB2 mediates the effectiveness of neratinib in the suppression of ErbB2-positive ovarian cancer.

Wang S, Zhang J, Wang T, Ren F, Liu X, Lu Y, Xu L, Zhang Y, Wang D, Xu L, Wu Y, Liu F, Li Q, Zaky MY, Liu S, Dong W, Liu F, Zou K, Zhang Y. Wang S, et al. Among authors: wang t, wang d. Int J Biochem Cell Biol. 2019 Dec;117:105640. doi: 10.1016/j.biocel.2019.105640. Epub 2019 Nov 2. Int J Biochem Cell Biol. 2019. PMID: 31689531

9

Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met.

Zaky MY, Liu X, Wang T, Wang S, Liu F, Wang D, Wu Y, Zhang Y, Guo D, Sun Q, Li Q, Zhang J, Zhang Y, Dong W, Liu Z, Liu S, Liu H. Zaky MY, et al. Among authors: wang t, wang d, wang s. Arch Biochem Biophys. 2020 Feb 15;680:108239. doi: 10.1016/j.abb.2019.108239. Epub 2019 Dec 24. Arch Biochem Biophys. 2020. PMID: 31881189

10

The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer.

Zhang J, Liu S, Li Q, Shi Y, Wu Y, Liu F, Wang S, Zaky MY, Yousuf W, Sun Q, Guo D, Wang T, Zhang Y, Wang Y, Li M, Liu H. Zhang J, et al. Among authors: wang y, wang t, wang s. Cell Death Differ. 2020 Sep;27(9):2710-2725. doi: 10.1038/s41418-020-0538-8. Epub 2020 Apr 23. Cell Death Differ. 2020. PMID: 32327714 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51,517 results

Search Page

Filters